Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Iressa Versus Docetaxel (Taxotere)

NCT00076388

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Fountain Valley, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
View all 162 locations
View Trial Details
Completed

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

NCT00002506

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +46 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Bloomington Hospital Bloomington, Indiana, United States
  • St. Vincent Hospital and Health Care Center Indianapolis, Indiana, United States
  • Bergan Mercy Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer

NCT00317200

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Medical & Surgical Specialists, LLC Galesburg, Illinois, United States
  • Cancer Care Center of Southern Indiana Bloomington, Indiana, United States
  • Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States
View all 17 locations
View Trial Details
Completed

Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)

NCT00391274

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guangzhou, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China
View Trial Details

Related conditions